2021 Annual Conference - New Award Announcement
0 comments
by Thomas Willett
Dear members and friends of the Canadian Biomaterials Society, Announcing the CBS2021 Best Overall Presentation Award, sponsored by the Elsevier journal Biomaterials...
2021 Annual Conference - Second Call For Abstracts
0 comments
by Thomas Willett
Dear members and friends of the Canadian Biomaterials Society, The 36th Annual General Meeting will be held from May 13th to May 15th on Hopin, a virtual conference platform...
Bio & Nanomaterials in Tissue Engineering & Regene
0 comments
by Zhenwei Ma
Dear members of the Canadian Biomaterials Society, We are inviting you today to a Conference Series that is being organized by the BioEngineering and Therapeutic Solutions BEaTS Laboratory, in partnership with the Ottawa Student Chapter of the CBS CBS-OSC , the University of Ottawa, the University of Ottawa Heart Institute, and the University of Toronto...
2021 Annual Conference - Call For Abstracts
0 comments
by Thomas Willett
CALL FOR ABSTRACTS Dear members and friends of the Canadian Biomaterials Society, The 36th Annual General Meeting, hosted by the University of Waterloo, will be held from May 13th to May 15th on Hopin, a virtual conference platform...
Injectable hydrogels have received much attention to be used as scaffolds for therapeutic cell delivery because of their interesting properties such as biocompatibility, ability to retain water, insignificant mechanical and frictional irritation with the native tissue and having the possibility to be located in the body through minimally invasive operations...
The bioactivity i.e., the ability of carbonate hydroxyapatite CHA formation to promote bone bonding of 45S5 Bioglass has been studied over four decades...
Design and evaluation of a polymer hydrogel scaffold for the delivery of adipose-derived stem cells for the treatment of peripheral arterial disease
comments
Over 800 000 Canadians suffer from peripheral arterial disease PAD 1, a condition which leads to critical limb ischemia and high risks of amputation and mortality...
Following cataract surgery, 20- 40 of patients experience reduced or afflicted vision via the development of posterior capsule opacification PCO , or secondary cataracts 1 ...